Dow Geoffrey S's Form 4 filing
60 Degrees Pharmaceuticals, Inc. (SXTP) · filed Nov 21, 2024
- Accession no.
- 0001213900-24-101110
- Filed
- Nov 21, 2024
- Trade date
- Nov 19-21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $6.36K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dow Geoffrey SCIK 0001977231 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | Common Stock | PPurchaseAcquired | +2,500 | $0.90 | +$2,250 | 16,129 | Direct | |
| Nov 20, 2024 | Common Stock | PPurchaseAcquired | +1,000 | $0.92 | +$920 | 17,129 | Direct | |
| Nov 21, 2024 | Common Stock | PPurchaseAcquired | +3,500 | $0.91 | +$3,185 | 20,629 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.